Other
Net Change in Cash
Royalty Pharma Net Change in Cash increased by 89.9% to -$32.30M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 120.4%, from $158.69M to -$32.30M. Over 2 years (FY 2022 to FY 2025), Net Change in Cash shows a downward trend with a 35.2% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementCash Flow Statement
SectionOther
CategoryLiquidity
SignalHigher is better
VolatilityVolatile
First reportedQ1 2017
Last reportedQ1 2026
How to read this metric
A positive change indicates net cash generation, while a negative change indicates cash consumption for the period.
Detailed definition
The total net increase or decrease in cash, cash equivalents, and restricted cash during the reporting period. It is the...
Peer comparison
A fundamental liquidity metric used to compare cash management efficiency across all public companies.
Metric ID:
net_change_in_cashHistorical Data
17 periods
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $433.47M | $658.53M | $250.47M | $316.52M | -$1.12B | $719.12M | $264.94M | $197.39M | -$1.24B | -$459.44M | $365.99M | $921.64M | $158.69M | -$455.81M | $307.04M | -$320.25M | -$32.30M |
| QoQ Change | — | +51.9% | -62.0% | +26.4% | -452.7% | +164.4% | -63.2% | -25.5% | -726.5% | +62.8% | +179.7% | +151.8% | -82.8% | -387.2% | +167.4% | -204.3% | +89.9% |
| YoY Change | — | — | — | -27.0% | -269.5% | — | +5.8% | -37.6% | -10.8% | -163.9% | +38.1% | +366.9% | -56.6% | -149.5% | — | — | -120.4% |
Range-$1.24B – $921.64M
CAGR-47.8%
Avg YoY Growth-38.6%
Median YoY Growth-37.6%
Net Change in Cash at Other Companies
Frequently Asked Questions
- What is Royalty Pharma's net change in cash?
- Royalty Pharma (RPRX) reported net change in cash of -$32.30M in Q1 2026.
- How has Royalty Pharma's net change in cash changed year-over-year?
- Royalty Pharma's net change in cash decreased by 120.4% year-over-year, from $158.69M to -$32.30M.
- What is the long-term trend for Royalty Pharma's net change in cash?
- Over 2 years (2022 to 2025), Royalty Pharma's net change in cash has grown at a 35.2% compound annual growth rate (CAGR), from $169.70M to -$310.33M.
- What does net change in cash mean?
- The total change in the company's cash position over the period.